QuartrQuartr

TORNTPHARM: Revenue rose 51%, but PAT fell as merger integration weighed on JB business

Lesedauer weniger als 1 min

Q2 FY27 revenue rose 51% YoY to Rs 4,979 crore and operating EBITDA grew 54%, while PAT fell 9.6%. Base business grew 18%; JB integration and German supply issues weighed on select operations.

Original document: Torrent Pharmaceuticals Ltd [TORNTPHARM] Interim report — Oct. 23 2026

Haftungsausschluss